Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-8.11%
|
$3,360,000
$56.28 P/Share
|
|
Mar 15
2021
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
6,692
-33.34%
|
$368,060
$55.5 P/Share
|
|
Mar 15
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-7.5%
|
$3,300,000
$55.75 P/Share
|
|
Mar 01
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
43,613
-33.14%
|
$2,355,102
$54.5 P/Share
|
|
Feb 24
2021
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
17,020
-99.24%
|
$902,060
$53.08 P/Share
|
|
Feb 23
2021
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,346
-100.0%
|
$67,300
$50.05 P/Share
|
|
Feb 23
2021
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-49.03%
|
$69,930
$54.29 P/Share
|
|
Feb 23
2021
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,641
+50.0%
|
-
|
|
Feb 23
2021
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
17,027
-13.84%
|
$919,458
$54.29 P/Share
|
|
Feb 23
2021
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
37,112
+23.18%
|
-
|
|
Feb 23
2021
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
14,000
-41.09%
|
$756,000
$54.29 P/Share
|
|
Feb 23
2021
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
27,518
+44.68%
|
-
|
|
Feb 23
2021
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
75,090
-49.58%
|
$4,054,860
$54.29 P/Share
|
|
Feb 23
2021
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
151,446
+50.0%
|
-
|
|
Feb 23
2021
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
53,188
-49.58%
|
$2,872,152
$54.29 P/Share
|
|
Feb 23
2021
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
107,272
+50.0%
|
-
|
|
Feb 23
2021
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,189
-100.0%
|
$699,017
$53.0 P/Share
|
|
Feb 23
2021
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,524
-46.63%
|
$622,296
$54.29 P/Share
|
|
Feb 23
2021
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,713
+50.0%
|
-
|
|
Feb 23
2021
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.1%
|
$10,314
$54.29 P/Share
|
|
Feb 23
2021
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
17,211
+49.81%
|
-
|
|
Feb 23
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,410
-1.06%
|
$76,140
$54.29 P/Share
|
|
Feb 23
2021
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
128,524
+29.63%
|
-
|
|
Feb 23
2021
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
800,000
+50.0%
|
-
|
|
Feb 19
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
28,234
-86.24%
|
$1,524,636
$54.78 P/Share
|
|
Feb 18
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
72,064
-35.07%
|
$3,963,520
$55.03 P/Share
|
|
Feb 16
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
61,987
-20.47%
|
$3,347,298
$54.93 P/Share
|
|
Feb 12
2021
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,116
-2.4%
|
$112,148
$53.99 P/Share
|
|
Feb 12
2021
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
4,609
+4.98%
|
-
|
|
Feb 12
2021
|
Kenneth Shropshire |
SELL
Open market or private sale
|
Direct |
1,645
-22.27%
|
$88,830
$54.69 P/Share
|
|
Dec 29
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
45
+3.06%
|
-
|
|
Dec 29
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
56
+3.96%
|
-
|
|
Dec 29
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
55
+3.95%
|
-
|
|
Dec 29
2020
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+3.96%
|
-
|
|
Dec 29
2020
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+3.95%
|
-
|
|
Dec 29
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
10
+2.91%
|
-
|
|
Dec 29
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
56
+3.96%
|
-
|
|
Dec 29
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
55
+3.95%
|
-
|
|
Dec 15
2020
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
3,267
-33.26%
|
$147,015
$45.0 P/Share
|
|
Dec 15
2020
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
3,267
+24.96%
|
-
|
|
Dec 15
2020
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-100.0%
|
$54,855
$45.0 P/Share
|
|
Dec 15
2020
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,219
+50.0%
|
-
|
|
Nov 30
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.72%
|
-
|
|
Nov 30
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.91%
|
-
|
|
Nov 30
2020
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.93%
|
-
|
|
Nov 30
2020
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.91%
|
-
|
|
Nov 30
2020
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.93%
|
-
|
|
Nov 30
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.61%
|
-
|
|
Nov 30
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.91%
|
-
|
|
Nov 30
2020
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.93%
|
-
|